Published: 2017-04-26

Clinical study of ventilator-associated pneumonia in tertiary care hospital, Kolhapur, Maharashtra, India

Babasaheb Deshmukh, Suhas Kadam, Thirumugam M., Rajesh K.


Background: Ventilator‑associated pneumonia (VAP) is the most common nosocomial infection acquired by patients admitted in the intensive care unit (ICU). However, there is very less information or clinical data available on the occurrence of VAP in Kolhapur, Maharashtra.

Methods: study aims to determine the Incidence of VAP in ICU, to study the association between causative microorganism and sensitivity, and to study the association between prognosis and incidence of VAP. Settings and Design: Tertiary level, medical‑surgical ICU; prospective, observational study.

Results: Patients coming to Medicine Department of the hospital subjected to mechanical ventilation for more than 48 hours in critical Care Facility during the period of two years May 2014 to April 2016.

Conclusions: In the incidence of VAP was found to be 78% among ICU patients. Majority (36%) patients had diabetes mellitus, 30% had hypertension before the admission. It is observed that chances of developing VAP were more in patients with co-morbid conditions. The microbiological results of Endotracheal Aspirate showed that, majority 36% had pseudomonas, 26% had Acinetobacter, 22% had no growth, 14% staphylococci (Staphylococcus is a gram-positive, round-shaped bacterium that is a member of the Firmicutes, and is frequently found in the nose, respiratory tract, and on the skin), 2% proteus mirabilis as compared to similar studies. Out of all, Pseudomonas is the most commonly isolated organism. This could be attributed to decreased immunity and a compromised general condition due to associated illness. Also, prolonged hospital stay is also of significance.


Antibiotics, Incidence, Infection, ICU, microbiological profile, Outcome, VAP

Full Text:



Koenig SM, Truwit JD. Ventilator-associated pneumonia: diagnosis, treatment, and prevention. Clin Microbiol Rev. 2006;19(4):637-57.

Ranjan N, Chaudhary U, Chaudhry D, Ranjan KP. Ventilator-associated pneumonia in a tertiary care intensive care unit:Analysis of incidence , risk factors and mortality. Indian J Crit Care Med. 2014;18(4):200-4.

Saravu K, Preethi V, Kumar R, Guddattu V, Shastry AB. Determinants of ventilator associated pneumonia and its impact on prognosis:A tertiary care experience. Indian J Crit Care Med. 2016;17(6):337-42.

Gupta A, Agrawal A, Mehrotra S, Singh A, Malik S, Khanna A. Incidence, risk stratification, antibiogram of pathogens isolated and clinical outcome of ventilator associated pneumonia. Indian J Crit Care Med. 2011;15(2):96-101.

Khilnani GC, Jain N. Ventilator ­ Associated Pneumonia :Changing microbiology and implications. Indian J Crit Care Med. 2013;17(6):331-2.

Kalanuria AA, Zai W, Mirski M. Ventilator-associated pneumonia in the ICU. Crit Care, Bio Med Cent. 2014;18:208.

Wagh H, Acharya D. Ventilator Associated Pneumonia - an Overview. Br J Med Pract. 2009;2(2):16-9.

The Canadian Critical Care Trials Group. A Randomized Trial of Diagnostic Techniques for Ventilator-Associated Pneumonia. N Engl J Med. 2006;355(25):2619-30.

Peter J, Chacko B, Moran J. Comparison of closed endotracheal suction versus open endotracheal suction in the development of ventilator-associated pneumonia in intensive care patients: an evaluation using meta-analytic techniques. Indian journal of medical sciences. 2007;61(4):201-11.

Wip C, Napolitano L. Bundles to prevent ventilator-associated pneumonia: how valuable are they? Curr Opin Infect Dis. 2009;22(2):159-166.

Rakshit P, Nagar VS, Deshpande AK. Incidence, clinical outcome, and risk stratification of ventilator-associated pneumonia - a prospective cohort study. Indian J Crit Care Med. 2005;9(4):211-6.

Rodrigues DO, Cezário RC, Filho PPG. Ventilator-Associated Pneumonia (VAP) caused by Multidrug-Resistant (MDR) Pseudomonas aeruginosa vs. other microorganisms at an adult clinical-surgical intensive care unit in a Brazilian University Hospital: Risk factors and outcomes. Int J Med Med Sci. 2009;1(10):432-7.

Joseph NM, Sistla S, Dutta T, Badhe A. Ventilator-associated pneumonia in a tertiary care hospital in India: Incidence and risk factors. J Infect Dev C tries. 2009;3(10):771-7.

Morehead RS, Pinto SJ. Ventilator-Associated Pneumonia. Arch Intern Med. 2000;160:1926-36.

Gadani H, Vyas A, Kar AK. A study of ventilator ­ associated pneumonia: Incidence, outcome, risk factors and measures to be taken for prevention. Indian J Anaesth. 2010;54(6):535-40.

Mukhopadhyay C, Bhargava A, Ayyagari A. Role of mechanical ventilation and development of multidrug resistant organisms in hospital acquired pneumonia. Indian J Med Res. 2003;118:229-35.

Chastre J, Fagon J. Ventilator-associated Pneumonia. Am J Respir Crit Care Med. 2002;165:867-903.

Torres A, Carlet J. Ventilator-associated pneumonia. European Task Force on ventilator-associated pneumonia. Eur Respir J. 2001;17(5):1034-45.

Rello J, Ollendorf DA, Oster G, Vera - Llonch M, Bellm L, Redman R, Kollef MH. Epidemiology and outcomes of ventilator-associated pneumonia in a large US database. Chest Journal. 2002;122(6):2115-21.

Brennan MT, Bahrani-Mougeot F, Fox PC, Kennedy TP, Hopkins S, Boucher RC, Lockhart PB. The role of oral microbial colonization in ventilator-associated pneumonia. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology. 2004;98(6):665-72.